You are here:

follitropin delta (Rekovelle)

Advice

in the absence of a submission from the holder of the marketing authorisation

follitropin delta (Rekovelle®) is not recommended for use within NHS Scotland.

Indication under review: Controlled ovarian stimulation for the development of multiple follicles in women undergoing assisted reproductive technologies such as an in vitro fertilisation or intracytoplasmic sperm injection cycle.

The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication.  As a result we cannot recommend its use within NHSScotland.

Drug Details

Drug Name: follitropin delta (Rekovelle)
SMC Drug ID: 1269/17
Manufacturer: Ferring Pharmaceuticals Ltd
Indication: controlled ovarian stimulation for the development of multiple follicles in women undergoing assisted reproductive technologies such as an in vitro fertilisation or intracytoplasmic sperm injection cycle.
BNF Category:
Submission Type: Non submission
Status: Not Recommended
Date Advice Published: 7 August 2017

Back